Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) trial (abstract 1161) - Dans, AM; Ezekowitz, M; Wallentin, L (Eur Heart J, 2011)
et al.